FilingFirehose · custom report

CABR — Caring Brands, Inc.

SEC filings analysis · 6 filings reviewed (last 12 months) · generated 2026-07-20 14:44 UTC

Executive summary

Caring Brands, Inc. (CABR) filed six 8-K reports over the last 12 months, with the most significant activity occurring in mid-July 2026 when the company disclosed a material agreement or transaction (Item 1.01) alongside amendments to bylaws and certificate of incorporation (Items 3.02, 3.03) and financial statements/exhibits (Item 9.01). The filing pattern suggests corporate restructuring or capital-raising activity, though specific dollar amounts and transaction details are not disclosed in the available metadata. No ATM shelf offerings, financing activities, or quantified dilution events are evident from these filings.

Dilution risk 2/5

While the July 2026 filings show amendments to certificate of incorporation (Item 3.03) and bylaws (Item 3.02)—actions sometimes associated with share authorization changes—no explicit evidence of active share issuance, warrant exercise, or equity compensation is present in the filing metadata. The score reflects moderate caution given structural amendments without transparency regarding capitalization impact.

Item 3.03 (amendments to certificate of incorporation) filed 2026-07-16
Item 3.02 (bylaws amendment) filed 2026-07-16
No disclosed ATM shelf offerings or equity issuance details in available filings

Notable filings (6)

2026-07-16 8-K	Material agreement or transaction disclosed alongside corporate charter and bylaw amendments with financial statement exhibit. · filing The bundle of Items 1.01 (material agreement), 3.02 (bylaws), 3.03 (certificate), and 9.01 (financial statements) suggests a significant M&A transaction, financing arrangement, or recapitalization. The near-simultaneous amendments indicate structural changes required to complete or govern the transaction. Investors should obtain the full filing to understand deal terms, consideration, and capitalization impact.
2026-07-17 8-K	Amendment to certificate of incorporation filed. · filing The filing of Item 3.01 one day after the major transaction disclosure may reflect a corrective or supplemental amendment. Without the full document text, the precise nature (share class adjustment, voting rights, authorized shares) cannot be determined, but timing suggests connection to the July 16 transaction.
2026-07-14 8-K	Costs associated with exit or disposal activities disclosed. · filing Item 5.07 typically signals restructuring charges, facility closures, or workforce reductions. The timing two days before the major transaction filing suggests the company may be announcing costs associated with integrating an acquisition, divesting assets, or restructuring operations.
2026-06-01 8-K	Regulation FD disclosure and financial statements/exhibit filed. · filing Item 7.01 (regulation FD disclosures) combined with Item 9.01 (financial statements) indicates the company disclosed material nonpublic information to investors or analysts. This may relate to operating results, guidance, or transaction details intended to level the information field.
2026-05-29 8-K	Other event disclosed under Item 8.01. · filing This catch-all item often signals material information the company did not classify under other categories—potentially strategic announcements, shareholder communications, or third-party actions. The lack of more specific item coding limits interpretation without viewing the full document.
2026-04-10 8-K	Amendment to certificate of incorporation filed. · filing Item 3.01 disclosure in April represents an earlier corporate charter amendment, possibly authorizing share classes or modifying voting rights in preparation for subsequent financing or transaction activity visible in July filings.

Financing activity

No ATM shelf offerings, registered direct offerings, or quantified financing transactions are disclosed in the available 8-K metadata for the 12-month period. However, the July 2026 filings (accession 0001493152-26-033575) disclose a material agreement (Item 1.01) and related financial statements, suggesting a capital-raising or M&A transaction whose specific terms and dollar amounts are not visible in the metadata extract.

Risk signals

Repeated certificate of incorporation amendments (April 2026 and July 2026) without disclosed rationale raise questions about share authorization, voting structure, or anti-dilution provisions—obtain full amendment text to assess shareholder impact.
Material agreement disclosure (Item 1.01, July 16) bundled with corporate restructuring charges (Item 5.07, July 14) suggests M&A or divestiture; transaction terms, consideration, and earnout provisions are not visible in available metadata and require review of full 8-K exhibits.
Regulation FD disclosure (Item 7.01, June 1) indicates material nonpublic information was selectively communicated; verify that all investors received substantially concurrent public disclosure to confirm compliance and identify any undisclosed operational or financial risks.
Six 8-K filings in 12 months with four filed within a 3-day window (July 14-17) suggests either high operational volatility or rushed disclosure processing; monitor for gaps in transparency or late/amended filings that may indicate remedial SEC issues.
No quantifiable financial data (acquisition price, synergies, debt incurred, or share count impact) is provided in the filing metadata, limiting ability to assess whether recent transactions are accretive or dilutive to earnings per share—full prospectus and balance sheet analysis is essential.
Item 9.01 financial statements are referenced in two filings (June 1 and July 16) but not summarized; ensure exhibits include audited or reviewed financials and understand whether they reflect pro forma or carve-out results for acquired/divested entities.

Bottom line

Caring Brands disclosed significant corporate activity in the 12-month period, centered on a material transaction in July 2026 accompanied by charter and bylaw amendments and restructuring charges. Given the limited transparency in available filing metadata and absence of quantified financial data, an investor should obtain and carefully review the full 8-K exhibits, including the material agreement (Item 1.01), certificate amendments (Item 3.03), and financial statements (Item 9.01) to assess transaction terms, dilution impact, and integration costs before making an investment decision.

View this report online